Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in vaccinated children who developed Haemophilus disease.
Weinberg
G A
GA
Edward Mallinckrodt Dept of Pediatrics, Washington University School of Medicine, St Louis, MO.
Murphy
T V
TV
Granoff
D M
DM
D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D004168:Diphtheria Toxoid / Q000008:administration & dosage / Q000276:immunology*; D005260:Female; D006192:Haemophilus Infections / Q000097:blood / Q000276:immunology* / Q000517:prevention & control; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology; D007223:Infant; D008297:Male; D014611:Vaccination
D001428:Bacterial Vaccines; D004168:Diphtheria Toxoid; D018073:Haemophilus Vaccines; C052180:Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate; D007136:Immunoglobulins